1. Executive Summary

2. Global Top 50 Blockbuster Drugs Market Size& Analysis (2015 – 2025)

3. Global Top 50 Blockbuster Drugs Market Share & Y–o–Y Growth (%), 2015 – 2025

4. Key Drivers and Inhibitors of the Global Blockbuster Drugs Market
4.1 Market Drivers
4.2 Market Inhibitors

5. Global Top 50 Blockbuster Drugs Market Assessment & Opportunity, (2015 – 2025)
5.1 Humira (Adalimumab)
5.2 Imbruvica (Ibrutinib)
5.3 Revlimid (Lenalidomide)
5.4 Pomalyst/Imnovid (Pomalidomide)
5.5 Genvoya (Cobicistat; Elvitegravir; Emtricitabine; Tenofovir Alafenamide fumarate)
5.6 Truvada (Emtricitabine / Tenofovir)
5.7 Harvoni (Ledipasvir / Sofosbuvir)
5.8 Epclusa (Sofosbuvir / Velpatasvir)
5.9 Keytruda (Pembrolizumab)
5.10 Januvia/Janumet (Sitagliptin / Metformin)
5.11 Herceptin (Trastuzumab)
5.12 Avastin (Bevacizumab)
5.13 MabThera/Rituxan (Rituximab)
5.14 Perjeta (Pertuzumab)
5.15 Opdivo (Nivolumab)
5.16 Eliquis (Apixaban)
5.17 Orencia (Abatacept)
5.18 Sprycel (Dasatinib)
5.19 Lyrica (Pregabalin)
5.20 Ibrance (Palbociclib)
5.21 Simponi (Golimumab)
5.22 Stelara (Ustekinumab)
5.23 Zytiga (Abiraterone acetate)
5.24 Invega Sustenna (Paliperidone)
5.25 Xarelto (Rivaroxaban)
5.26 Tagrisso (Osimertinib)
5.27 Enbrel (Etanercept)
5.28 Eylea (Aflibercept)
5.29 Victoza (Liraglutide)
5.30 Botox (Botulinum toxin)
5.31 Soliris (Eculizumab)
5.32 Triumeq (Abacavir / Dolutegravir / Lamivudine)
5.33 Seretide/Advair (Fluticasone propionate / Salmeterol)
5.34 Gilenya (Fingolimod)
5.35 Cosentyx (Secukinumab)
5.36 Trulicity (Dulaglutide)
5.37 Humalog (Insulin Lispro)
5.38 Cialis (Tadalafil)
5.39 Symbicort (Budesonide / Formoterol)
5.40 Zapatier (Elbasvir / Grazoprevir)
5.41 Tecfidera (Dimethyl fumarate)
5.42 Darzalex (Daratumumab)
5.43 Prolia/Xgeva (Denosumab)
5.44 Ocrevus (Ocrelizumab)
5.45 Xtandi (Enzalutamide)
5.46 Tivicay (Dolutegravir)
5.47 Jakafi/Jakavi (Ruxolitinib Phosphate)
5.48 Jardiance (Empagliflozin)
5.49 Trajenta/Jentadueto (Linagliptin)
5.50 Relvar/Breo Ellipta (Fluticasone furoate / Vilanterol)

6. Most Valuable Drugs Research and Development (R&D) Projects Insights by Phase and Market Value

7. Global Research & Development (R&D) Spend by Pharma & Biotech Companies (2015 – 2025)

8. Major Deals (Mergers, Acquisitions, Key Agreements, Partnerships & Collaborations)

9. Key Companies Analysis
9.1 AbbVie
9.1.1 Business Overview
9.1.2 Recent Development
9.2 Celgene
9.2.1 Business Overview
9.2.2 Recent Development
9.3 Gilead Science
9.3.1 Business Overview
9.3.2 Recent Development
9.4 Merck
9.4.1 Business Overview
9.4.2 Recent Development
9.5 Roche
9.5.1 Business Overview
9.5.2 Recent Development
9.6 Bristol–Myers Squibb
9.6.1 Business Overview
9.6.2 Recent Development
9.7 Pfizer
9.7.1 Business Overview
9.7.2 Recent Development
9.8 Johnson & Johnson
9.8.1 Business Overview
9.8.2 Recent Development
9.9 Amgen
9.9.1 Business Overview
9.9.2 Recent Development
9.10 Biogen
9.10.1 Business Overview
9.10.2 Recent Development
9.11 Bayer
9.11.1 Business Overview
9.11.2 Recent Development
9.12 Regeneron Pharmaceuticals
9.12.1 Business Overview
9.12.2 Recent Development
9.13 Novo Nordisk
9.13.1 Business Overview
9.13.2 Recent Development
9.14 Allergan
9.14.1 Business Overview
9.14.2 Recent Development
9.15 Alexion pharmaceuticals
9.15.1 Business Overview
9.15.2 Recent Development
9.16 GlaxoSmithKline
9.16.1 Business Overview
9.16.2 Recent Development
9.17 Novartis
9.17.1 Business Overview
9.17.2 Recent Development
9.18 Eli Lilly and Company
9.18.1 Business Overview
9.18.2 Recent Development
9.19 Astrazeneca
9.19.1 Business Overview
9.19.2 Recent Development
9.20 Incyte Corporation
9.20.1 Business Overview
9.20.2 Recent Development
9.21 Boehringer Ingelheim
9.21.1 Business Overview
9.21.2 Recent Development
9.22 Astellas Pharma
9.22.1 Business Overview
9.22.2 Recent DevelopmentList of Tables

Table 3–1: Global Top 50 Blockbuster Drugs Market Share & Y–o–Y Growth (%), 2015 – 2017
Table 3–2: Global Top 50 Blockbuster Drugs Market Share & Y–o–Y Growth Forecast (%), 2018 – 2025
Table 6–1: Most Valuable Drugs R&D Projects Insights by Phase and Market Value
Table 8–1: Collaboration Deals
Table 8–2: Merger and Acquisitions
Table 8–3: Licensing Agreement
Table 8–4: Partnership Deals

List of Figures

Figure 2–1: Global Top 50 Blockbuster Drugs Market Siz (Billion US$),2015 – 2017
Figure 2–2: Global Top 50 Blockbuster Drugs Market Size Forecast (Billion US$),2018 – 2025
Figure 5–1: Global Humira Market Value (Million US$),2015 – 2017
Figure 5–2: Global Humira Market Value Forecast (Million US$),2018 – 2025
Figure 5–3: Global Imbruvica Market Value (Million US$),2015 – 2017
Figure 5–4: Global Imbruvica Market Value Forecast (Million US$),2018 – 2025
Figure 5–5: Global Revlimid Market Value (Million US$),2015 – 2017
Figure 5–6: Global Revlimid Market Value Forecast (Million US$),2018 – 2025
Figure 5–7: Global Pomalyst/Imnovid Market Value (Million US$),2015 – 2017
Figure 5–8: Global Pomalyst/Imnovid Market Value Forecast (Million US$),2018 – 2025
Figure 5–9: Global Genvoya Market Value (Million US$),2015 – 2017
Figure 5–10: Global Genvoya Market Value Forecast (Million US$),2018 – 2025
Figure 5–11: Global Truvada Market Value (Million US$),2015 – 2017
Figure 5–12: Global Truvada Market Value Forecast (Million US$),2018 – 2025
Figure 5–13: Global Harvoni Market Value (Million US$),2015 – 2017
Figure 5–14: Global Harvoni Market Value Forecast (Million US$),2018 – 2025
Figure 5–15: Global Epclusa Market Value (Million US$),2015 – 2017
Figure 5–16: Global Epclusa Market Value Forecast (Million US$),2018 – 2025
Figure 5–17: Global Keytruda Market Value (Million US$),2015 – 2017
Figure 5–18: Global Keytruda Market Value Forecast (Million US$),2018 – 2025
Figure 5–19: Global Januvia/Janumet Market Value (Million US$),2015 – 2017
Figure 5–20: Global Januvia/Janumet Market Value Forecast (Million US$),2018 – 2025
Figure 5–21: Global Herceptin Market Value (Million US$),2015 – 2017
Figure 5–22: Global Herceptin Market Value Forecast (Million US$),2018 – 2025
Figure 5–23: Global Avastin Market Value (Million US$),2015 – 2017
Figure 5–24: Global Avastin Market Value Forecast (Million US$),2018 – 2025
Figure 5–25: Global MabThera/Rituxan Market Value (Million US$),2015 – 2017
Figure 5–26: Global MabThera/Rituxan Market Value Forecast (Million US$),2018 – 2025
Figure 5–27: Global Perjeta Market Value (Million US$),2015 – 2017
Figure 5–28: Global Perjeta Market Value Forecast (Million US$),2018 – 2025
Figure 5–29: Global Opdivo Market Value (Million US$),2015 – 2017
Figure 5–30: Global Opdivo Market Value Forecast (Million US$),2018 – 2025
Figure 5–31: Global Eliquis Market Value (Million US$),2015 – 2017
Figure 5–32: Global Eliquis Market Value Forecast (Million US$),2018 – 2025
Figure 5–33: Global Orencia Market Value (Million US$),2015 – 2017
Figure 5–34: Global Orencia Market Value Forecast (Million US$),2018 – 2025
Figure 5–35: Global Sprycel Market Value (Million US$),2015 – 2017
Figure 5–36: Global Sprycel Market Value Forecast (Million US$),2018 – 2025
Figure 5–37: Global Lyrica Market Value (Million US$),2015 – 2017
Figure 5–38: Global Lyrica Market Value Forecast (Million US$),2018 – 2025
Figure 5–39: Global Ibrance Market Value (Million US$),2015 – 2017
Figure 5–40: Global Ibrance Market Value Forecast (Million US$),2018 – 2025
Figure 5–41: Global Simponi Market Value (Million US$),2015 – 2017
Figure 5–42: Global Simponi Market Value Forecast (Million US$),2018 – 2025
Figure 5–43: Global Stelara Market Value (Million US$),2015 – 2017
Figure 5–44: Global Stelara Market Value Forecast (Million US$),2018 – 2025
Figure 5–45: Global Zytiga Market Value (Million US$),2015 – 2017
Figure 5–46: Global Zytiga Market Value Forecast (Million US$),2018 – 2025
Figure 5–47: Global Invega Sustenna Market Value (Million US$),2015 – 2017
Figure 5–48: Global Invega Sustenna Market Value Forecast (Million US$),2018 – 2025
Figure 5–49: Global Xarelto Market Value (Million US$),2015 – 2017
Figure 5–50: Global Xarelto Market Value Forecast (Million US$),2018 – 2025
Figure 5–51: Global Tagrisso Market Value (Million US$),2015 – 2017
Figure 5–52: Global Tagrisso Market Value Forecast (Million US$),2018 – 2025
Figure 5–53: Global Enbrel Market Value (Million US$),2015 – 2017
Figure 5–54: Global Enbrel Market Value Forecast (Million US$),2018 – 2025
Figure 5–55: Global Eylea Market Value (Million US$),2015 – 2017
Figure 5–56: Global Eylea Market Value Forecast (Million US$),2018 – 2025
Figure 5–57: Global Victoza Market Value (Million US$),2015 – 2017
Figure 5–58: Global Victoza Market Value Forecast (Million US$),2018 – 2025
Figure 5–59: Global Botox Market Value (Million US$),2015 – 2017
Figure 5–60: Global Botox Market Value Forecast (Million US$),2018 – 2025
Figure 5–61: Global Soliris Market Value (Million US$),2015 – 2017
Figure 5–62: Global Soliris Market Value Forecast (Million US$),2018 – 2025
Figure 5–63: Global Triumeq Market Value (Million US$),2015 – 2017
Figure 5–64: Global Triumeq Market Value Forecast (Million US$),2018 – 2025
Figure 5–65: Global Seretide/Advair Market Value (Million US$),2015 – 2017
Figure 5–66: Global Seretide/Advair Market Value Forecast (Million US$),2018 – 2025
Figure 5–67: Global Gilenya Market Value (Million US$),2015 – 2017
Figure 5–68: Global Gilenya Market Value Forecast (Million US$),2018 – 2025
Figure 5–69: Global Cosentyx Market Value (Million US$),2015 – 2017
Figure 5–70: Global Cosentyx Market Value Forecast (Million US$),2018 – 2025
Figure 5–71: Global Trulicity Market Value (Million US$),2015 – 2017
Figure 5–72: Global Trulicity Market Value Forecast (Million US$),2018 – 2025
Figure 5–73: Global Humalog Market Value (Million US$),2015 – 2017
Figure 5–74: Global Humalog Market Value Forecast (Million US$),2018 – 2025
Figure 5–75: Global Cialis Market Value (Million US$),2015 – 2017
Figure 5–76: Global Cialis Market Value Forecast (Million US$),2018 – 2025
Figure 5–77: Global Symbicort Market Value (Million US$),2015 – 2017
Figure 5–78: Global Symbicort Market Value Forecast (Million US$),2018 – 2025
Figure 5–79: Global Zapatier Market Value (Million US$),2015 – 2017
Figure 5–80: Global Zapatier Market Value Forecast (Million US$),2018 – 2025
Figure 5–81: Global Tacfidera Market Value (Million US$),2015 – 2017
Figure 5–82: Global Tacfidera Market Value Forecast (Million US$),2018 – 2025
Figure 5–83: Global Darzalex Market Value (Million US$),2015 – 2017
Figure 5–84: Global Darzalex Market Value Forecast (Million US$),2018 – 2025
Figure 5–85: Global Prolia/Xgeva Market Value (Million US$),2015 – 2017
Figure 5–86: Global Prolia/Xgeva Market Value Forecast (Million US$),2018 – 2025
Figure 5–87: Global Ocrevus Market & Forecast Value (Million US$),2017 – 2025
Figure 5–88: Global Xtandi Market Value (Million US$),2015 – 2017
Figure 5–89: Global Xtandi Market Value Forecast (Million US$),2018 – 2025
Figure 5–90: Global Tivicay Market Value (Million US$),2015 – 2017
Figure 5–91: Global Tivicay Market Value Forecast (Million US$),2018 – 2025
Figure 5–92: Global Jakafi/Jakavi Market Value (Million US$),2015 – 2017
Figure 5–93: Global Jakafi/Jakavi Market Value Forecast (Million US$),2018 – 2025
Figure 5–94: Global Jardiance Market Value (Million US$),2015 – 2017
Figure 5–95: Global Jardiance Market Value Forecast (Million US$),2018 – 2025
Figure 5–96: Global Trajenta/Jentadueto Market Value (Million US$),2015 – 2017
Figure 5–97: Global Trajenta/Jentadueto Market Value Forecast (Million US$),2018 – 2025
Figure 5–98: Global Relvar/Breo Ellipta Market Value (Million US$),2015 – 2017
Figure 5–99: Global Relvar/Breo Ellipta Market Value Forecast (Million US$),2018 – 2025
Figure 7–1: Global R&D Spend by Pharma & Biotech Companies,2015 – 2025